The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.

The Nutrition Center warns people who want to lose weight not to take medication too lightly. “It may seem easy, but do not ...

Medications sold under brand names like Ozempic, Wegovy, and Saxenda have become famous for their weight-loss benefits, but ...

As weight-loss injections like Mounjaro and Wegovy soar in popularity across the UK, jewellers say they’re seeing an unexpected side effect: wedding and engagement rings no longer fit, and in they are ...

Both well-established and small, clinical-stage pharma companies are investing heavily to be able to someday compete with ...

The NHS rollout of Wegovy and Mounjaro will be scaled up, the Government has promised – without setting a date for when it ...

Wall Street's smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all ...

They burst onto the scene four years ago and are taking over the pharmaceutical world. New GLP-1-based drugs like Ozempic, Wegovy or Zepbound are said to be a weight-loss game changer and could drive ...

Novo Nordisk A/S (NYSE:NVO) ranks among the best set-it-and-forget-it stocks to buy. Novo Nordisk A/S (NYSE:NVO) announced on ...

VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.

A nurse has warned about a common Mounjaro ‘mistake’ that can increase people’s risk of deadly organ damage.

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.